Table 2.
Study phase | Description |
---|---|
I | Study carried out to assess a new approach in a small sample for the first time to evaluate its safety, determine a safe dosage range, and identify side effects |
II | Approach is given to a larger sample to see if it is effective, further evaluate safety, and determine optimal dose |
III | Approach is to a large sample to confirm effectiveness, monitor side effects, make comparisons to commonly used treatments, and collect information that will allow the approach to be used safely |
IV | Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use |
I, II, II, IV, from clinicaltrial.org.